Opus GeneticsIRD
13F holders, Q1 2024 (March 31)49holders
3famous investors
$2.01avg. 13F price*
At the end of Q1 2024, 49 institutions reported holding Opus Genetics Inc. (IRD) in their 13F filings. The largest holders were Vanguard Group Inc. ($2.0M), Rice Hall James & Associates, LLC ($587K) and Geode Capital Management, LLC ($471K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Opus Genetics Inc.
- Filed as
- OCUPHIRE PHARMA INC (Q1 2024)
- CUSIP
- 67577R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $268K |
| Exits | 9 | $694K |
Ownership 49 holders
| Vanguard Group Inc. | 0.00% | Add +6.9% | 992,200 | $2.0M |
| Rice Hall James & Associates, LLC | 0.03% | Reduce -48.9% | 291,985 | $587K |
| Geode Capital Management, LLC | 0.00% | Add +7.0% | 234,398 | $471K |
| Richmond Brothers, Inc. | 0.85% | Reduce -10.0% | 227,461 | $457K |
| MAI Capital Management | 0.00% | Reduce -42.9% | 223,970 | $450K |
| Bridgeway Capital Management, LLC | 0.01% | Add +21.1% | 209,941 | $422K |
| Renaissance Technologies | 0.00% | Add +458.5% | 135,300 | $272K |
| Knoll Capital Management, LLC | 0.13% | No change | 100,000 | $201K |
| BlackRock Inc. | 0.00% | Add +2.5% | 96,714 | $194K |
| Citadel Advisors | 0.00% | Add +420.6% | 79,530 | $160K |
| State Street Corp. | 0.00% | No change | 70,473 | $142K |
| American Century Companies Inc. | 0.00% | Add +9.4% | 65,911 | $132K |
| Morgan Stanley | 0.00% | No change | 56,114 | $113K |
| Northern Trust Corp. | 0.00% | No change | 51,925 | $104K |
| Diametric Capital, LP | 0.06% | Reduce -29.9% | 51,394 | $103K |
| Susquehanna International Group, LLP | 0.00% | Add +91.8% | 42,590 | $86K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 42,341 | $85K |
| Mackenzie Financial Corp. | 0.00% | New | 40,814 | $82K |
| Millennium Management | 0.00% | Reduce -57.3% | 36,628 | $74K |
| Empowered Funds, LLC | 0.00% | New | 36,605 | $74K |
| Blair William & Co. | 0.00% | No change | 33,267 | $67K |
| Trust Co. of Toledo NA | 0.01% | No change | 30,963 | $62K |
| Comerica Bank | 0.00% | No change | 30,000 | $60K |
| Prelude Capital Management, LLC | 0.00% | Reduce -22.7% | 20,618 | $41K |
| HRT Financial LP | 0.00% | New | 19,868 | $39K |
| Captrust Financial Advisors | 0.00% | No change | 18,000 | $36K |
| Virtu Financial LLC | 0.00% | New | 17,752 | $36K |
| Prudential Financial Inc. | 0.00% | Add +29.9% | 17,400 | $35K |
| Osaic Holdings, Inc. | 0.00% | Reduce -4.6% | 16,509 | $33K |
| Bedel Financial Consulting, Inc. | 0.00% | No change | 15,000 | $30K |
| UBS Group AG | 0.00% | Add +163.6% | 14,228 | $29K |
| Stokes Family Office, LLC | 0.00% | No change | 12,120 | $24K |
| Lincoln National Corp. | 0.00% | Add +1.7% | 11,900 | $24K |
| Summit Trail Advisors, LLC | 0.00% | New | 10,545 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,376 | $15K |
| Wells Fargo & Company | 0.00% | Add +0.5% | 2,966 | $6K |
| Simplex Trading, LLC | 0.00% | Reduce -78.7% | 2,134 | $4K |
| National Bank of Canada | 0.00% | No change | 2,000 | $3K |
| Concourse Financial Group Securities, Inc. | 0.00% | No change | 1,182 | $2K |
| Toth Financial Advisory Corp. | 0.00% | No change | 1,001 | $2K |
| CarsonAllaria Wealth Management, Ltd. | 0.00% | No change | 1,000 | $2K |
| Optimum Investment Advisors | 0.00% | No change | 1,000 | $2K |
| Towne Trust Company, N.A | 0.00% | New | 500 | $1K |
| Lanark Financial, Inc. | 0.00% | No change | 600 | $1K |
| Harbour Investments, Inc. | 0.00% | New | 40 | $80 |
| Rhumbline Advisers | 0.00% | No change | 29 | $58 |
| ICA Group Wealth Management, LLC | 0.00% | Reduce -66.7% | 10 | $20 |
| FSA Wealth Management LLC | 0.00% | No change | 5 | $10 |
| Royal Bank of Canada | 0.00% | Reduce -100.0% | 5 | $0 |
"% of holder's portfolio" is IRD's weight in each manager's 13F, not the share of Opus Genetics Inc. the manager owns.